Ultrasound findings after screening for down syndrome using the integrated test

Obstetrics and Gynecology

Volumn 109, Issue 5, 2007, Pages 1046-1052

  Weisz, Boaz ^a,b   Pandya, Pranav P ^a   David, Anna L ^a   Huttly, Wayne ^a   Jones, Patricia ^a   Rodeck, Charles H ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AMNIOCENTESIS; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOWN SYNDROME; FEMALE; FETUS; FETUS MALFORMATION; HUMAN; INCIDENCE; KARYOTYPING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING; STATISTICAL ANALYSIS; ULTRASOUND;

ADOLESCENT; ADULT; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MIDDLE AGED; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ULTRASONOGRAPHY, PRENATAL;

EID: 34247551800     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000260234.20190.6e     Document Type: Article

References (32)

1. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999 Aug 12;341:461-7.
2. Marteau TM, Kidd J, Michie S, Cook R, Johnston M, Shaw RW. Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: a randomized controlled trial. J Psychosom Obstet Gynaecol 1993;14:185-96.
3. Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. SURUSS in perspective. BJOG 2004;111:521-31.
4. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005 Nov 10;353:2001-11.
5. Bricker L, Garcia J, Henderson J, Mugford M, Neilson J, Roberts T, et al. Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views. Health Technol Assess 2000;4:1-193.
6. Benacerraf BR, Neuberg D, Bromley B, Frigoletto FD Jr. Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med 1992;11:449-58.
7. Bahado-Singh RO, Tan A, Deren O, Hunter D, Copel J, Mahoney MJ. Risk of Down syndrome and any clinically significant chromosome defect in pregnancies with abnormal triple-screen and normal targeted ultrasonographic results. Am J Obstet Gynecol 1996;175:824-9.
8. Vintzileos AM, Campbell WA, Rodis JF, Guzman ER, Smulian JC, Knuppel RA. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 2132. Obstet Gynecol 1996;87:948-52.
9. Winter TC, Uhrich SB, Souter VL, Nyberg DA. The "genetic sonogram": comparison of the index scoring system with the age-adjusted US risk assessment. Radiology 2000;215:775-82.
10. Nyberg DA, Souter VL. Sonographic markers of fetal trisomies: second trimester. J Ultrasound Med 2001;20:655-74.
11. Smith-Bindman R, Feldstein VA, Goldberg JD. The genetic sonogram in screening for Down syndrome. J Ultrasound Med 2001;20:1153-8.
12. Bahado-Singh RO, Mendilcioglu I, Rowther M, Choi SJ, Oz U, Yousefi NF, et al. Early genetic sonogram for Down syndrome detection. Am J Obstet Gynecol 2002;187:1235-8.
13. Bromley B, Lieberman E, Shipp TD, Benacerraf BR. The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med 2002;21:1097-8.
14. Hobbins JC, Lezotte DC, Persutte WH, DeVore GR, Benacerraf BR, Nyberg DA, et al. An 8-center study to evaluate the utility of mid-term genetic sonograms among high-risk pregnancies. J Ultrasound Med 2003;22:33-8.
15. Nyberg DA, Souter VL. Use of genetic sonography for adjusting the risk for fetal Down syndrome 7. Semin Perinatol 2003;27:130-44.
16. Bromley B, Benacerraf BR. The Genetic Sonogram Scoring Index. Semin Perinatol 2003;27:124-9.
17. Egan JF. The genetic sonogram in second trimester down syndrome screening. Clin Obstet Gynecol 2003;46:897-908.
18. Stewart TL. Screening for aneuploidy: the genetic sonogram. Obstet Gynecol Clin North Am 2004;31:21-33.
19. Verdin SM, Whitlow BJ, Lazanakis M, Kadir RA, Chatzipapas I, Economides DL. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry. Ultrasound Obstet Gynecol 2000;16:402-6.
20. Vintzileos AM, Guzman ER, Smulian JC, McLean DA, Ananth CV. Choice of second-trimester genetic sonogram for detection of trisomy 21. Obstet Gynecol 1997;90:187-90.
21. Bahado-Singh RO, Tan A, Deren O, Hunter D, Copel J, Mahoney MJ. Risk of Down syndrome and any clinically significant chromosome defect in pregnancies with abnormal triple-screen and normal targeted ultrasonographic results. Am J Obstet Gynecol 1996;175:824-9.
22. Verdin SM, Economides DL. The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry. Br J Obstet Gynaecol 1998;105:63-7.
23. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004;191:45-67.
24. Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 1998;12:8-14.
25. Nicolaides KH. Screening for chromosomal defects. Ultrasound Obstet Gynecol 2003;21:313-21.
26. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 2003;10:56-104.
27. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221-6.
28. Gilbert RE, Augood C, Gupta R, Ades AE, Logan S, Sculpher M, et al. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ 2001;323:423-5.
29. Getz L, Kirkengen AL. Ultrasound screening in pregnancy: advancing technology, soft markers for fetal chromosomal aberrations, and unacknowledged ethical dilemmas. Soc Sci Med 2003;56:2045-57.
30. Bromley B, Lieberman E, Benacerraf BR. The incorporation of maternal age into the sonographic scoring index for the detection at 14-20 weeks of fetuses with Down's syndrome. Ultrasound Obstet Gynecol 1997;10:321-4.
31. Cicero S, Sonek JD, McKenna DS, Croom CS, Johnson L, Nicolaides KH. Nasal bone hypoplasia in trisomy 21 at 15-22 weeks' gestation. Ultrasound Obstet Gynecol 2003;21:15-8.
32. Vintzileos A, Walters C, Yeo L. Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high-risk population. Obstet Gynecol 2003;101:905-8.